Arbutus Biopharma shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Arbutus Biopharma
Tip: Access up to 7 years of quarterly data
All positions including Arbutus Biopharma held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Arbutus Biopharma by MetLife Investment Advisors
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $148k | 59k | 2.50 |
2023-09-30 | $120k | 59k | 2.03 |
2023-06-30 | $136k | 59k | 2.30 |
2023-03-31 | $179k | 59k | 3.03 |
2022-12-31 | $103k | 44k | 2.33 |
2022-09-30 | $112k | 59k | 1.91 |
2022-06-30 | $95k | 35k | 2.71 |
2022-03-31 | $118k | 40k | 2.98 |
2021-12-31 | $39k | 10k | 3.89 |
2021-09-30 | $129k | 30k | 4.29 |
2018-09-30 | $270k | 29k | 9.45 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors